Treatment Response in Individual Organs Affected by Chronic Graft-Versus-Host Disease

Chronic graft-versus-host disease (GVHD) occurs in 30–70% of patients after allogeneic hematopoietic cell transplantation (HCT) and increases the risks of morbidity and mortality. Systemic corticosteroids are the standard initial treatment, but one-third of patients require subsequent treatment with...

Cijeli opis

Bibliografski detalji

Glavni autori:	Takanobu Morishita, Paul J. Martin, Yoshihiro Inamoto
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2025-02-01
Serija:	Cells
Teme:	keyword allogeneic hematopoietic cell transplantation chronic graft-versus-host disease organ response extracorporeal photopheresis ibrutinib ruxolitinib
Online pristup:	https://www.mdpi.com/2073-4409/14/4/238
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!